Archives: Episode

Check out this week’s QuadCast as we highlight major findings from ASCO 2024! Learn about immunotherapy neoadjuvantly for Stage III melanoma, the role of osimertinib in localized NSCLC, the role of short vs. long course ADT in salvage prostate treatment, and much more.

Check out this week’s Quadcast where we highlight the role of FMISO PET to identify tumor hypoxia for attempts at dose de-escalation in HPV mediated HNSCC, ASTRO’s new guidelines on bone metastasis treatment, SBRT for mediastinal LNs, and more.

Check out this week’s QuadCast as we highlight optimal treatment for locally recurrent endometrial cancer, the use of GARD in nasopharyngeal cancer, improved survival outcomes with patient portal utilization, and more.

Check out this week’s QuadCast as we highlight a simpler approach to concurrent chemo for esophageal cancer, the importance of age in endometrial cancer, the benefits of a plant-based diet in prostate cancer, and more.

Check out this week’s Quadcast as we highlight SBRT for oligoprogressive prostate cancer, salvage SRS for high risk meningiomas, changes in breast cancer screening recommendations, and more!

Check out this week’s QuadCast as we highlight a better RT dosing schedule for vulvar cancer, metastasis directed therapy for nasopharyngeal cancer, PSMA targeted treatments, and more.

Check out this week’s episode of the QuadCast where we highlight the PFS benefit of pembro in cervical cancer, the benefit of adjuvant RT in thymic carcinoma, a novel agent for GBM, and a handy calculator for re-irradiation.

Check out this week’s QuadCast as we highlight pembro + CRT for head and neck cancer, the benefit of treating the primary tumor in NSCLC with brain mets, the potential protection of estrogen against head and neck cancer, and more.

Check out the latest QuadCast where we highlight the results of the NATALEE trial, long term CONVERT results for SCLC, Gray Matter changes after SRS for Trigeminal Neuralgia, and more.

Check out this week’s QuadCast where we highlight omission of the low neck in nasopharyngeal radiation treatment, the benefits of HDR boost over LDR boost for prostate cancer, and more.